 Matthew Bolt
Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diet, High-Fat | 3 | 2026 | 261 | 0.590 |
Why?
| | Vaginal Birth after Cesarean | 2 | 2021 | 27 | 0.350 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1980 | 0.320 |
Why?
| | Fetal Growth Retardation | 2 | 2024 | 587 | 0.270 |
Why?
| | Healthcare Failure Mode and Effect Analysis | 1 | 2026 | 2 | 0.240 |
Why?
| | Estrogens | 2 | 2026 | 380 | 0.230 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2025 | 36 | 0.230 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 1 | 2025 | 13 | 0.230 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2026 | 149 | 0.220 |
Why?
| | Metabolic Syndrome | 2 | 2026 | 354 | 0.220 |
Why?
| | Arterioles | 1 | 2025 | 56 | 0.220 |
Why?
| | Aromatase Inhibitors | 1 | 2025 | 75 | 0.220 |
Why?
| | Cardiorespiratory Fitness | 1 | 2025 | 72 | 0.220 |
Why?
| | Chorionic Villi | 1 | 2024 | 25 | 0.210 |
Why?
| | Adipokines | 1 | 2024 | 57 | 0.210 |
Why?
| | Vasoconstriction | 1 | 2025 | 217 | 0.200 |
Why?
| | Quality Assurance, Health Care | 1 | 2026 | 340 | 0.200 |
Why?
| | Intention | 1 | 2025 | 183 | 0.200 |
Why?
| | Corpus Callosum | 1 | 2024 | 72 | 0.200 |
Why?
| | Umbilical Arteries | 1 | 2024 | 52 | 0.200 |
Why?
| | Oximetry | 1 | 2024 | 126 | 0.200 |
Why?
| | Sputum | 1 | 2025 | 308 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2024 | 67 | 0.190 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2025 | 246 | 0.190 |
Why?
| | Transforming Growth Factor beta | 1 | 2025 | 479 | 0.180 |
Why?
| | Ultrasonography, Prenatal | 1 | 2024 | 294 | 0.180 |
Why?
| | Sexual Behavior | 1 | 2025 | 491 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2025 | 395 | 0.170 |
Why?
| | Genetic Counseling | 1 | 2021 | 81 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2026 | 1053 | 0.170 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2022 | 142 | 0.160 |
Why?
| | Cancer Survivors | 1 | 2025 | 327 | 0.160 |
Why?
| | Prenatal Diagnosis | 1 | 2021 | 195 | 0.150 |
Why?
| | Students | 1 | 2025 | 663 | 0.150 |
Why?
| | Waiting Lists | 1 | 2021 | 263 | 0.150 |
Why?
| | Hippocampus | 1 | 2025 | 965 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2024 | 365 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2023 | 497 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 450 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 1 | 2025 | 885 | 0.140 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 965 | 0.140 |
Why?
| | Organ Transplantation | 1 | 2021 | 247 | 0.140 |
Why?
| | Biomarkers | 3 | 2025 | 4271 | 0.140 |
Why?
| | Health Surveys | 1 | 2020 | 518 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2024 | 916 | 0.140 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 888 | 0.130 |
Why?
| | Anticoagulants | 1 | 2023 | 722 | 0.130 |
Why?
| | Models, Statistical | 1 | 2022 | 681 | 0.130 |
Why?
| | Placenta | 1 | 2024 | 780 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2025 | 1414 | 0.120 |
Why?
| | Cytokines | 1 | 2024 | 2061 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1169 | 0.120 |
Why?
| | Female | 16 | 2026 | 78271 | 0.110 |
Why?
| | Healthcare Disparities | 1 | 2021 | 727 | 0.110 |
Why?
| | Humans | 18 | 2026 | 144759 | 0.100 |
Why?
| | Mental Health | 1 | 2020 | 790 | 0.100 |
Why?
| | Exercise | 1 | 2025 | 2201 | 0.100 |
Why?
| | Registries | 1 | 2022 | 2385 | 0.100 |
Why?
| | Pregnancy | 5 | 2024 | 7190 | 0.090 |
Why?
| | Adult | 9 | 2026 | 40449 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2452 | 0.090 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5868 | 0.090 |
Why?
| | Colorado | 1 | 2022 | 4564 | 0.090 |
Why?
| | Trial of Labor | 2 | 2021 | 18 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2433 | 0.090 |
Why?
| | Latin America | 2 | 2021 | 94 | 0.090 |
Why?
| | World Health Organization | 2 | 2021 | 105 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1168 | 0.080 |
Why?
| | Parturition | 2 | 2021 | 69 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2025 | 2583 | 0.080 |
Why?
| | Young Adult | 5 | 2026 | 14105 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 3154 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2024 | 17066 | 0.060 |
Why?
| | Pregnanediol | 1 | 2026 | 22 | 0.060 |
Why?
| | Estrone | 1 | 2026 | 40 | 0.060 |
Why?
| | Zambia | 1 | 2025 | 57 | 0.060 |
Why?
| | Myography | 1 | 2025 | 13 | 0.060 |
Why?
| | Luteinizing Hormone | 1 | 2026 | 190 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 2026 | 140 | 0.060 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2025 | 69 | 0.060 |
Why?
| | Follicle Stimulating Hormone | 1 | 2026 | 249 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2025 | 235 | 0.050 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.050 |
Why?
| | Ovariectomy | 1 | 2025 | 162 | 0.050 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.050 |
Why?
| | Accelerometry | 1 | 2025 | 119 | 0.050 |
Why?
| | Cerebellar Vermis | 1 | 2024 | 5 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2024 | 56 | 0.050 |
Why?
| | Aged | 4 | 2025 | 25913 | 0.050 |
Why?
| | Hypogonadism | 1 | 2024 | 90 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 126 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 547 | 0.050 |
Why?
| | Uterine Hemorrhage | 1 | 2023 | 41 | 0.050 |
Why?
| | Universities | 1 | 2025 | 452 | 0.050 |
Why?
| | Mucin-5B | 1 | 2025 | 234 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 452 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2025 | 724 | 0.050 |
Why?
| | Cohort Studies | 2 | 2024 | 5960 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2024 | 289 | 0.050 |
Why?
| | Vitamins | 1 | 2023 | 178 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 35875 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 509 | 0.040 |
Why?
| | Aneuploidy | 1 | 2021 | 90 | 0.040 |
Why?
| | Ukraine | 1 | 2020 | 35 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2023 | 291 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2025 | 897 | 0.040 |
Why?
| | Premature Birth | 1 | 2024 | 380 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 10779 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2112 | 0.040 |
Why?
| | Male | 5 | 2025 | 72315 | 0.040 |
Why?
| | Adolescent | 3 | 2025 | 22428 | 0.040 |
Why?
| | Lung Diseases, Interstitial | 1 | 2025 | 660 | 0.040 |
Why?
| | Body Mass Index | 1 | 2026 | 2438 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 1326 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2025 | 1241 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 652 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 872 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2327 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2025 | 2730 | 0.030 |
Why?
| | Sleep | 1 | 2022 | 901 | 0.030 |
Why?
| | Aging | 1 | 2025 | 1966 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5992 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2878 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6048 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7990 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2020 | 1094 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 3077 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6429 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8265 | 0.020 |
Why?
| | Mice | 1 | 2025 | 18339 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10034 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11787 | 0.020 |
Why?
| | United States | 1 | 2021 | 15966 | 0.010 |
Why?
| | Animals | 1 | 2025 | 38058 | 0.010 |
Why?
| | Child | 1 | 2021 | 22633 | 0.010 |
Why?
|
|
Bolt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|